Home/Filings/4/0001179022-03-000243
4//SEC Filing

CHIANG YAWEN L 4

Accession 0001179022-03-000243

CIK 0001003929other

Filed

Oct 14, 8:00 PM ET

Accepted

Oct 15, 11:01 AM ET

Size

5.2 KB

Accession

0001179022-03-000243

Insider Transaction Report

Form 4
Period: 2003-10-13
CHIANG YAWEN L
VP-Mfg, Chf Scientific Officer
Transactions
  • Award

    Stock Option (right to buy)

    2003-10-13+50,00050,000 total
    Exercise: $4.78From: 2003-10-13Exp: 2013-10-13Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]Stock options vest according to the following schedule: (i) 15,000 upon completion of all preclinical studies for catheter used in Issuer's Phase II(b) clinical trial; (ii) 10,000 upon the Issuer's execution of a contract for Phase III trial manufacturer; (iii) 10,000 upon completion of VEGF-2 assay development plan for Phase III trial material; (iv) 15,000 upon completion of manufacturing of Phase III trial plasmid; and (v) all remaining unvested options on October 13, 2005.

Issuer

CORAUTUS GENETICS INC

CIK 0001003929

Entity typeother

Related Parties

1
  • filerCIK 0001218654

Filing Metadata

Form type
4
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 11:01 AM ET
Size
5.2 KB